Blocking Ant2 Protein Supercharges T Cells to Fight Cancer

Researchers have identified a method to enhance the effectiveness of the immune system’s T cells in attacking cancer by blocking a specific protein. On April 14, 2026, The Hebrew University of Jerusalem announced that blocking the protein known as Ant2 forces these cells to rewire how they generate and use energy.

This metabolic shift makes T cells more powerful, resilient, and more effective at locating and destroying cancer cells. The discovery suggests a new strategy for strengthening the body’s natural defenses to provide a more precise approach to cancer therapy.

Metabolic Reprogramming of T Cells

T cells play a central role in the body’s immune defense. The research indicates that when these cells are forced to alter their energy conversion processes, their ability to detect and attack tumors improves significantly.

By blocking the Ant2 protein, scientists were able to reprogram the internal power supply of the T cells. This transformation makes the cells more active and durable, allowing them to operate more efficiently against cancer cells.

This process of metabolic reprogramming essentially rewires the energy engines of the immune cells, which allows them to hit tumors harder and work more intelligently.

International Research Collaboration

The study was led by PhD student Omri Yosef and Prof. Michael Berger from the Faculty of Medicine at Hebrew University. The project involved an international collaboration to determine how adjusting immune cell metabolism impacts cancer elimination.

The team included the following researchers and institutions:

• Prof. Michael Berger and PhD student Omri Yosef of the Faculty of Medicine at Hebrew University
• Prof. Magdalena Huber of Philipps University of Marburg
• Prof. Eyal Gottlieb of the University of Texas MD Anderson Cancer Center

Together, these researchers found that fine-tuning the metabolism of T cells dramatically improves their capacity to destroy cancer.

Implications for Future Cancer Treatment

The findings point toward the development of next-generation cancer treatments. By training the immune system to respond more aggressively and efficiently, medical professionals may be able to unlock new ways to fight tumors.

This approach focuses on the body’s own immune response, offering a targeted method of therapy. The research highlights the potential of adjusting how immune cells handle energy to increase their potency and resilience during the fight against cancer.